Track topics on Twitter Track topics that are important to you
Oragenics, Inc. biopharmaceutical company is engaged in developing proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer healthcare market. The company also has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic areas of infectious diseases, diagnostics and oral health. The company is located at 3000 Bayport Drive, Suite 685, Tampa, Florida and has R&D facilities in Progress Corporate Park at 13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the campus of the University of Florida in Gainesville.
US-based antibiotics developer Oragenics has started dosing patients in a Phase II clinical trial of AG013 for the treatment of oral mucositis (OM).
Oragenics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Oragenics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...
Life Sciences Jobs ...
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ORAGENICS IN...
Florida-based biopharmaceutical company Oragenics, Inc. (NYSE American: OGEN) (the “Company”) today announced receipt of notification from the NYSE American LLC (the “Exch...
Oragenics, Inc. (NYSE MKT:OGEN), a leader in the development of novel antibiotics against infectious diseases and innovative treatments for oral mucositis, today announced that it...
Oragenics, Inc. (NYSE MKT: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that the ...
Oragenics, Inc. (NYSE MKT:OGEN), a clinical stage biotechnology company, today announced that it has completed the second closing contemplated by the previously disclosed securiti...
Oragenics is a publicly held biopharmaceutical company trading on the American Stock Exchange under the symbol ONI. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Ala...
Oragenics, Inc. biopharmaceutical company is engaged in developing proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer ...
We have published hundreds of Oragenics, Inc. news stories on BioPortfolio along with dozens of Oragenics, Inc. Clinical Trials and PubMed Articles about Oragenics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oragenics, Inc. Companies in our database. You can also find out about relevant Oragenics, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...